Skip to main content
. 2022 Mar 12;46:101344. doi: 10.1016/j.eclinm.2022.101344

Figure 3.

Fig 3

Association between age and COVID-19 outcomes after the first dose of the Oxford-AstraZeneca or Pfizer-BioNTech vaccines over the 14 to 84 day follow-up period

Restricted cubic splines displaying hazard ratios of COVID-19 outcomes with 95% confidence intervals (dotted lines). The reference for each hazard ratio was the outcome in the unvaccinated group at corresponding ages. The 95% confidence intervals (dotted lines) are based on 10,000 predictions from the model using bootstrapped samples of the corresponding age-specific outcome counts. The spline for documented SARs-CoV-2 infection was adjusted by testing rate at baseline.